Skip to content

Titan Medical Merges with Conavi Medical


Titan Medical Inc. (“Titan”) announced on March 18, 2024, that it is merging with Conavi Medical Inc. (“Conavi”).

Titan is a medical technology licensing company based in Toronto with an extensive patent portfolio focusing on robotic assisted surgery.  Conavi is a medical device company specializing in minimally invasive image-guidance technology for cardiovascular procedures.

The agreement provides that Titan will exchange its own stock for all of Conavi’s outstanding shares, imputing a $69.8 million value for Conavi.

According to Titan’s press release, “[t]he combined company will focus on continuing to commercialize Conavi’s Novasight Hybrid™ System designed to guide common minimally invasive coronary procedures.”  The Novasight Hybrid™ System utilizes both intravascular ultrasound and optical coherence tomography to perform imaging of coronary arteries, providing the user with two different perspectives on the same part of the vessel.  The Novasight Hybrid™ System is also the first and only system to have this type of hybrid imaging on a single console, thus providing a more cost- and space-effective option for imaging technology.

Thomas Looby, CEO of Conavi, believes that this merger will “enhance [Conavi’s] financial strength” and will enable Conavi “to unlock the full potential of [its] hybrid imaging technology in the United States and globally.”

“Conavi is an exciting commercial-stage company with groundbreaking technology and an accomplished management team,” said Interim Titan CEO and Board Chair, Paul Cataford.  “We are confident in their ability to continue to drive adoption of the Novasight Hybrid System.”

The merger is expected to finalize on July 15, 2024.


, , , , , , , ,

Titan Medical Merges with Conavi Medical Headshot

Adam Copeland

Adam Copeland is an associate based in the firm's San Diego office.

Adam graduated cum laude from Washington University School of Law in St. Louis in 2022, and graduated summa cum laude with a B.S. in physics from Montana State University in 2019. While in law school, Adam primarily enjoyed engaging with first-year law students as a legal writing teaching assistant, helping them hone their skills in factual analysis and legal writing. Adam was also fortunate to have worked closely for two federal judges during law school: once as an intern for the Honorable Roseann A. Ketchmark in the Western District of Missouri, and once as an extern for the Honorable Nancy J. Rosenstengle in the Southern District of Illinois.

While serving as primary editor of the Washington University Global Studies Law Review, Adam received a Mary Collier Hitchcock prize for outstanding writing for his note regarding the problem of—and potential solutions to—frivolous lawsuits filed in the intellectual property field.

Adam joined the firm in 2022.

View all posts published by Adam Copeland
By using this blog, you agree and understand that no information is being provided in the context of any attorney-client relationship. You further agree and understand that nothing herein is intended to be legal advice. This blog is solely informational in nature, and is not intended as, and should not be used as, a substitute for competent legal advice from a retained and licensed attorney in your state. Knobbe Martens LLP makes no representations or warranties as to the accuracy, completeness, timeliness or availability of the information in this blog. Knobbe Martens LLP will not be liable for any injury or damages relating to your use of, or access to, any such information. Knobbe Martens LLP undertakes no obligation to correct or update information on this blog, which may be incorrect or become incorrect or out of date over time. Knobbe Martens LLP reserves the right to alter or delete content or information on the blog at any time. This blog contains links and references to other websites and publications that you may find of interest. Knobbe Martens LLP does not control, promote, endorse or otherwise have any affiliation with any other websites or publications unless those websites or publications expressly state such an affiliation. Knobbe Martens LLP further has no responsibility for, and makes no representations regarding, the content, accuracy or any other aspect of the information in such websites or publications.
close modal